A universal light-controlled highly sensitive one-pot CRISPR/Cas12a diagnostic based on structure-engineered crRNA
Trends in Biotechnology · 2026
DOI: 10.1016/j.tibtech.2026.03.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Trends in Biotechnology, 2026. Verfasst von Jieyu Cui und 13 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Educ…. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Clustered Regularly Interspaced Short Palindromic Repeats, Nucleic Acid Amplification Techniques, Molecular Diagnostic Techniques. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: The Agricultural Science and Technology Innovation Program, National Natural Science Foundation of China.
Abstract (Originalsprache)
Clustered regularly interspaced short palindromic repeats (CRISPR)-based nucleic acid detection has transformed molecular diagnostics through its speed and accuracy; however, one-pot formats are often limited by sensitivity and field suitability. Herein, we developed a universal light-controlled high-sensitivity one-pot CRISPR/Cas12a testing (ULTRAt) platform based on structure-engineered CRISPR RNA (crRNA) scaffolds. By incorporating photocaged 6-nitropiperonyloxymethyl groups into the crRNA stem-loop, Cas12a activity is transiently suppressed during isothermal amplification via structural modulation, enabling efficient target enrichment. Subsequent UV irradiation removes the protecting groups, restoring the native conformation and activating robust trans-cleavage. ULTRAt achieves a limit of detection of two copies of monkeypox virus per reaction with a 15-min time-to-result, representing a 100-fold sensitivity improvement over conventional assays. The platform further supports single-nucleotide polymorphism discrimination and human papillomavirus 16/18 genotyping. Analysis of 91 clinical samples demonstrates strong concordance between ULTRAt and reference qPCR and sequencing assays. Collectively, ULTRAt enables rapid, ultra-sensitive, and versatile one-pot detection, supporting near-patient diagnostics and genotyping.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jili…
- State Key Laboratory of Genome and Multi-omics Technologies, Genome Analysis Laboratory of the Ministry of Agriculture and Rural Affairs, Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Scie…
- Guangzhou National Laboratory, Bio-island, Guangdong 510005, China.
- Laboratory of Organ Regeneration and Transplantation of The Ministry of Education, China-Singapore Belt and Road Joint Laboratory on Liver Disease Research, State Key Laboratory for Diagnosis and Treatment of Severe Zoo…
Förderung
- The Agricultural Science and Technology Innovation Program
- National Natural Science Foundation of China
Zitieren
APA
Cui, J., Zhang, L., Zhou, J., Shi, T., Wu, S., Dai, T., Hao, L., Pan, J., Lai, X., Lu, W., Huang, X., Li, Z., Lai, L., & Wang, X. (2026). A universal light-controlled highly sensitive one-pot CRISPR/Cas12a diagnostic based on structure-engineered crRNA. Trends in Biotechnology. https://doi.org/10.1016/j.tibtech.2026.03.018
Vancouver
Cui J, Zhang L, Zhou J, Shi T, Wu S, Dai T, et al. A universal light-controlled highly sensitive one-pot CRISPR/Cas12a diagnostic based on structure-engineered crRNA. Trends in Biotechnology. 2026. doi:10.1016/j.tibtech.2026.03.018
BibTeX
@article{Cui2026,
author = {Cui, Jieyu and Zhang, Lulu and Zhou, Jing and Shi, Ting and Wu, Shangyi and Dai, Tenghui and Hao, Lijun and Pan, Junjie and Lai, Xiaodan and Lu, Wentao and Huang, Xingxu and Li, Zhanjun and Lai, Liangxue and Wang, Xinjie},
title = {A universal light-controlled highly sensitive one-pot CRISPR/Cas12a diagnostic based on structure-engineered crRNA},
journal = {Trends in Biotechnology},
year = {2026},
doi = {10.1016/j.tibtech.2026.03.018}
}
EUVIMED